SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a hot topic after receiving FDA Fast Track designation for sonelokimab in a rare inflammatory disorder, driving strong community conviction that its highly-anticipated investor day will underscore significant undervaluation and reignite acquisition speculation.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending following a challenging Q4 earnings report that revealed declining U.S. sales and a weak 2026 outlook, leading to analyst downgrades and high short interest. Community discussion is split between concerns over the company's debt, potential dividend cuts, and ongoing CEO search versus optimism for a turnaround, short squeeze, or potential buyout at its current low valuation.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space Inc ($FJET) is trending as community sentiment points to a potential short squeeze fueled by its tiny float and high short interest, alongside anticipation of an FAA Space Launch license and broader market excitement for the space sector ahead of a rumored Space X IPO.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as its AXPAXLI drug successfully met the primary endpoint in the SOL-1 Phase 3 trial for wet AMD, demonstrating superiority over Eylea and offering a reduced treatment burden. Despite these positive results, the stock saw a significant sell-off driven by market concerns over the efficacy margin and control arm performance, sparking widespread debate among investors whether the reaction is an overcorrection or a fundamental reassessment.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Holdings Inc

Ondas Holdings is trending due to a flurry of new multi-million dollar contracts for its Iron Drone Raider in Europe and Sentrycs counter-UAS systems for German police, fueling community discussion about its growth as a "Mini-Anduril" in the booming defense technology sector and expectations of a potential short squeeze despite market volatility.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera Inc. is trending after its recent earnings call where management highlighted significant technical progress in Gate-All-Around and MST applications, expressing confidence in upcoming licensing deals and linking executive bonuses to commercial milestones. This has sparked community excitement about a potential short squeeze and acquisition speculation, though many remain wary given the company's history of low revenue and unfulfilled promises in the competitive semiconductor sector.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion (INFQ) is highly active after its recent NYSE debut following a SPAC merger, with the community bullish on its neutral atom quantum technology and significant partnerships with entities like NASA and NVIDIA, positioning it as a leading contender against other quantum sector peers.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is experiencing intense debate following impressive Q2 earnings and strong guidance, attributed to surging demand for its optical components in AI data centers. Bulls are celebrating its significant run as a critical AI infrastructure play, while bears vigorously argue it's extremely overvalued and due for a sharp correction.

Phoenix Asia Holdings Ltd. engages in the substructure works and other construction services. It offers site formation, ground investigation and foundation work through it subsidiary. The company was founded on August 9, 2024 and is headquartered in Hong Kong.

Phoenix Asia Holdings Ltd.

Phoenix Asia Holdings Ltd. (PHOE) is trending due to community speculation around its low float and high short interest, fueling discussions of an imminent short squeeze and drawing comparisons to other highly volatile "China plays." Recent corporate developments, including a franchise agreement and board expansion, also contribute to the heightened attention.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is actively discussed ahead of its earnings report, with community sentiment split between concerns that AI could disrupt cybersecurity and the belief that AI-powered solutions, like those from its significant Google Cloud partnership and recent acquisitions, will drive increased demand in the sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis

New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis...

Precigen, Inc. (NASDAQ:PGEN) Sees Large Growth in Short Interest

Precigen, Inc. (NASDAQ:PGEN - Get Free Report) saw a significant growth in short interest during the month of December. As of December 31st, there was short interest totaling 35,580,646 shares, a...

Precigen (NASDAQ:PGEN) Shares Gap Up - What's Next?

Precigen (NASDAQ:PGEN) Shares Gap Up - Here's What Happened...

Precigen, Inc. (NASDAQ:PGEN) Given Consensus Rating of "Moderate Buy" by Analysts

Precigen, Inc. (NASDAQ:PGEN - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the six analysts that are currently covering the company, MarketBeat Ratings reports. One...

Precigen (NASDAQ:PGEN) Trading Down 7.5% - What's Next?

Precigen (NASDAQ:PGEN) Shares Down 7.5% - Time to Sell...

Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference

Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference Precigen Showcases...

Iridian Asset Management LLC CT Sells 611,716 Shares of Precigen, Inc. $PGEN

Iridian Asset Management LLC CT cut its stake in Precigen, Inc. (NASDAQ:PGEN - Free Report) by 14.3% in the third quarter, according to the company in its most recent filing with the Securities and...

Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference

Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire GERMANTOWN, Md., Jan. 5, 2026 GERMANTOWN...

Precigen (NASDAQ:PGEN) Trading Down 6.1% - What's Next?

Precigen (NASDAQ:PGEN) Trading Down 6.1% - Here's Why...

Precigen (NASDAQ:PGEN) Trading Down 4.2% - Here's What Happened

Precigen (NASDAQ:PGEN) Shares Down 4.2% - Here's What Happened...

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the following segments: Biopharmaceuticals, Exemplar, and Trans Ova. The Biopharmaceuticals segment is involved in advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. It also engages in pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. The Exemplar segment is focused on developing research models and services for healthcare research applications. The Trans Ova segment provides bovine reproductive technologies. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Fundamental

Technical

A mix of both

Some investors focus on company fundamentals like earnings, growth, and valuation. Others rely on price action, trends, and momentum. Many use a combination of both to guide their decisions. What do you use?

What type of analysis drives your investment decisions?

Current Price	$5.40
Prev Close	$4.93
Open	$4.85
Dividend Yield	0.00%
50-Day Moving Average	$4.30
Beta	1.84
Avg. Volume	3.79M
PE Ratio	-3.52

52-Week High	$5.23
52-Week Low	$1.11
Market Capitalization	$1.77B
EPS (Annual)	-$0.4715
Price to Book	41.66
Revenue Per Employee	$27,447.55

PGEN
Precigen Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PGEN News

PGENPrecigen Inc